Seasonale (30 μg of ethinyl estradiol/150 μg of levonorgestrel) extended-regimen oral contraceptive: efficacy and cycle control by body weight
Westhoff, C.; Anderson, F.
Contraception 74(2): 181-182
2006
ISSN/ISBN: 0010-7824 Document Number: 255267
Document emailed within 1 workday
Related Documents
Westhoff, C.; Anderson, F. 2006: Seasonale (30 μg of ethinyl estradiol/150 μg of levonorgestrel) extended-regimen oral contraceptive: efficacy and cycle control by body weight Contraception 74(2): 181-182Krishnan, S.; Kiley, J. 2010: The lowest-dose, extended-cycle combined oral contraceptive pill with continuous ethinyl estradiol in the United States: a review of the literature on ethinyl estradiol 20 μg/levonorgestrel 100 μg + ethinyl estradiol 10 μg International Journal of Women's Health 2: 235-239
Portman, D.J.; Kaunitz, A.M.; Howard, B.; Weiss, H.; Hsieh, J.; Ricciotti, N. 2014: Efficacy and safety of an ascending-dose, extended-regimen levonorgestrel/ethinyl estradiol combined oral contraceptive Contraception 89(4): 299-306
Bjarnadóttir, R.I.; Tuppurainen, M.; Killick, S.R. 2002: Comparison of cycle control with a combined contraceptive vaginal ring and oral levonorgestrel/ethinyl estradiol American Journal of Obstetrics and Gynecology 186(3): 389-395
DelConte, A.; Loffer, F.; Grubb, G.S. 1999: Cycle control with oral contraceptives containing 20 micrograms of ethinyl estradiol. a multicenter, randomized comparison of levonorgestrel/ethinyl estradiol (100 micrograms/20 micrograms) and norethindrone/ethinyl estradiol (1000 micrograms/20 micrograms) Contraception 59(3): 187-193
LaGuardia, K.D.; Shangold, G.; Fisher, A.; Friedman, A.; Kafrissen, M. 2003: Efficacy, safety and cycle control of five oral contraceptive regimens containing norgestimate and ethinyl estradiol Contraception 67(6): 431-437
Lobo Abascal, P.; Luzar-Stiffler, V.; Giljanovic, S.; Howard, B.; Weiss, H.; Trussell, J. 2016: Differences in reporting Pearl Indices in the United States and Europe: Focus on a 91-day extended-regimen combined oral contraceptive with low-dose ethinyl estradiol supplementation European Journal of Contraception and Reproductive Health Care: the Official Journal of the European Society of Contraception 21(1): 88-91
Archer, D.F.; Maheux, R.; DelConte, A.; O'Brien, F.B. 1999: Efficacy and safety of a low-dose monophasic combination oral contraceptive containing 100 microg levonorgestrel and 20 microg ethinyl estradiol (Alesse). North american Levonorgestrel Study Group (NALSG) American Journal of Obstetrics and Gynecology 181(5 Pt 2): 39-44
Kashanian, M.; Shahpourian, F.; Zare, O. 2010: A comparison between monophasic levonorgestrel-ethinyl estradiol 150/30 and triphasic levonorgestrel-ethinyl estradiol 50-75-125/30-40-30 contraceptive pills for side effects and patient satisfaction: a study in Iran European Journal of Obstetrics Gynecology and Reproductive Biology 150(1): 47-51
Westhoff, C.L.; Hait, H.I.; Reape, K.Z. 2012: Body weight does not impact pregnancy rates during use of a low-dose extended-regimen 91-day oral contraceptive Contraception 85(3): 235-239
Molina, R.C.; Sandoval, J.Z.; Montero, A.V.; Oyarzún, P.G.; Molina, T.ís.G.; González, E.A. 2009: Comparative performance of a combined injectable contraceptive (50 mg norethisterone enanthate plus 5mg estradiol valerate) and a combined oral contraceptive (0.15 mg levonorgestrel plus 0.03 mg ethinyl estradiol) in adolescents Journal of Pediatric and Adolescent Gynecology 22(1): 25-31
Gaussem, P.; Alhenc-Gelas, M.; Thomas, J.-L.; Bachelot-Loza, C.; Remones, V.; Ali, F.D.; Aiach, M.; Scarabin, P.-Y. 2011: Haemostatic effects of a new combined oral contraceptive, nomegestrol acetate/17β-estradiol, compared with those of levonorgestrel/ethinyl estradiol. a double-blind, randomised study Thrombosis and Haemostasis 105(3): 560-567
Caruso, S.; Iraci Sareri, M.; Agnello, C.; Romano, M.; Lo Presti, L.; Malandrino, C.; Cianci, A. 2011: Conventional vs. extended-cycle oral contraceptives on the quality of sexual life: comparison between two regimens containing 3 mg drospirenone and 20 µg ethinyl estradiol Journal of Sexual Medicine 8(5): 1478-1485
Xin, X.; Wu, Y.; Liu, X.; Sun, C.; Geng, T.; Ding, L. 2016: Pharmacokinetics of Oral Combination Contraceptive Drugs Containing Ethinyl Estradiol and Levonorgestrel in Healthy Female Chinese Volunteers Drug Research 66(2): 100-106
Oner, G.; Muderris, I.I. 2011: A prospective randomized trial comparing low-dose ethinyl estradiol and drospirenone 24/4 combined oral contraceptive vs. ethinyl estradiol and drospirenone 21/7 combined oral contraceptive in the treatment of hirsutism Contraception 84(5): 508-511
Maloney, J.M.; Dietze, P.; Watson, D.; Niknian, M.; Lee-Rugh, S.; Sampson-Landers, C.; Korner, P. 2008: Treatment of acne using a 3-milligram drospirenone/20-microgram ethinyl estradiol oral contraceptive administered in a 24/4 regimen: a randomized controlled trial Obstetrics and Gynecology 112(4): 773-781
Sivasubramanian, R.; Chakraborty, A.; Rouzade-Dominguez, M.-L.; Neelakantham, S.; Jakab, A.; Mensinga, T.; Legangneux, E.; Woessner, R.; Ufer, M. 2015: Effect of mavoglurant (AFQ056), a selective mGluR5 antagonist, on the pharmacokinetics of a combined oral contraceptive containing ethinyl estradiol and levonorgestrel in healthy women International Journal of Clinical Pharmacology and Therapeutics 53(7): 550-556
Jensen, J.T. 2008: A continuous regimen of levonorgestrel/ethinyl estradiol for contraception and elimination of menstruation Drugs of Today 44(3): 183-195
Kroll, R.; Ackerman, R.; Feldman, R.; Howard, B.; Weiss, H.; Hsieh, J.; Ricciotti, N. 2016: Efficacy and safety of a 21/7-active combined oral contraceptive with continuous low-dose ethinyl estradiol Contraception 93(3): 249-256
Boerrigter, P.J.; Ellman, H.; Dolker, M. 1999: International clinical experience with a new low-dose, monophasic oral contraceptive containing levonorgestrel 100 microg and ethinyl estradiol 20 microg Clinical Therapeutics 21(1): 118-127